Search Results
Found 3 results
510(k) Data Aggregation
(108 days)
ShuntCheck is an aid to the detection of flow in implanted cerebrospinal fluid (CSF) shunts. ShuntCheck includes Micro-Pumper, a component which may be used to temporarily increase CSF flow in suspected non-flowing, patent shunts during the ShuntCheck test. ShuntCheck cannot alone diagnose CSF shunt function or malfunction. The clinical diagnosis of CSF shunt function or malfunction, incorporating the flow information from ShuntCheck, should be made only by a qualified neurosurgeon.
ShuntCheck is a non-invasive device which detects flow in a CSF shunt via transcutaneous thermal dilution. The device consists of a single use disposable thermosensor array patch which is connected to a data acquisition unit (a DAQ) which is connected to a laptop or tablet computer. The device also includes a Micro-Pumper which vibrates the shunt valve during the test procedure to generate a temporary increase in flow in patent but temporarily non-flowing shunts. The shunt is cooled transcutaneously by placing an instant ice pack over the shunt cephalic to the thermosensor. The thermosensor array patch, which is placed on the skin over the shunt "downstream" of the ice, reads the change in skin temperature over the shunt as cooled fluid flows downstream and also at a two nearby control locations. Data is transferred through the DAQ and captured in the computer. If the device detects a characteristic downstream transcutaneous temperature dip, the computer reports "flow confirmed" and presents a time-temperature graph of test data. If no temperature dip is detected, the unit reports "flow not confirmed" and presents a time-temperature graph.
The ShuntCheck III device is intended as an aid to detect flow in implanted cerebrospinal fluid (CSF) shunts. The study presented is a 510(k) submission for substantial equivalence to a predicate device, ShuntCheck v2.2. The evaluation includes both bench testing and limited clinical testing.
Here's a breakdown of the requested information:
1. Table of Acceptance Criteria and Reported Device Performance
Feature/Test | Acceptance Criteria (ShuntCheck III) | Reported Device Performance (ShuntCheck III) |
---|---|---|
Bench Testing without Micro-Pumper | ||
Detect flow of 10 ml/hr | Not explicitly defined, but predicate was 100% accurate | 100% (100% accurate) |
Detect flow of 0 ml/hr | Not explicitly defined, but predicate was 0% accurate | 0% (100% accurate) |
Threshold of detection | Not explicitly defined, but predicate was 5-7.5 ml/hr | Between 3.5 and 5 ml/hr (Improved) |
Detect 10 ml/hr flow with 20° rotation misalignment | Not explicitly defined, but predicate was 0% | 100% (Improved) |
Detect 10 ml/hr flow with 4mm lateral misplacement | Not explicitly defined, but predicate was 0% | 100% (Improved) |
Bench Testing with Micro-Pumper | ||
Shunt flow generated by Micro-Pumper (patent, non-flowing shunts at 0 ICP) | Generate flow in patent shunts, but not in occluded. No overdrainage. | 0.3 to 0.9 cc (Flow in patent non-flowing shunts) |
Shunt flow generated by Micro-Pumper (clogged shunts) | Generate flow in patent shunts, but not in occluded. No overdrainage. | 0.0 to 0.03 cc (Flow in clogged shunts) |
Max flow generated by Micro-Pumper (patent flowing shunts) | Generate flow in patent shunts, but not in occluded. No overdrainage. | 0.9 to 2.8 cc |
Impact on shunt valve function (change in natural flow) |
Ask a specific question about this device
(114 days)
ShuntCheck is an aid to the detection of flow in implanted cerebrospinal fluid (CSF) shunts. ShuntCheck cannot alone diagnose CSF shunt function or malfunction. The clinical diagnosis of CSF shunt function or malfunction, incorporating the flow information from ShuntCheck, should be made only by a qualified neurosurgeon.
ShuntCheck is a non-invasive device which detects flow in a CSF shunt via transcutaneous thermal convection. The device consists of a single use disposable thermosensor array patch which is connected to a handheld "biodisplay" unit. The shunt is cooled transcutaneously by placing ice over the shunt cephalic to the thermosensor. The thermosensor array patch, which is placed on the skin over the shunt "downstream" of the ice, reads the change in skin temperature over the shunt as cooled fluid flows downstream and also at a nearby control location. Data is captured in the biodisplay unit. If the device detects a characteristic downstream transcutaneous temperature dip, the biodisplay reports "flow confirmed". If no temperature dip is detected, the unit reports "flow not confirmed"
The provided text does not contain specific acceptance criteria or a detailed study description with performance metrics to fully answer all aspects of the request. The document is primarily a 510(k) summary and an FDA clearance letter for the ShuntCheck device, which is an aid to detect flow in CSF shunts. It mentions functional and safety testing, and animal studies, but does not provide quantitative acceptance criteria or detailed results of a clinical study that would demonstrate performance.
However, based on the available information, here's what can be extracted and inferred:
1. A table of acceptance criteria and the reported device performance
The document does not explicitly state quantitative acceptance criteria for device performance (e.g., sensitivity, specificity, accuracy thresholds) or provide reported device performance metrics in a clinical context. It mentions:
Acceptance Criteria (Implied) | Reported Device Performance (Implied from testing) |
---|---|
Accuracy of resistance readings/temperature output | Confirmed accurate when reading resistances (thermistor input simulation) and displaying expected temperature output. |
Functionality in detecting flow | Device was able to detect flow rates (ml/hr) in animal studies. Found substantially equivalent to predicate device (ShuntCheck version 1.1) in animal studies. |
Safety requirements compliance | Meets IEC 60601-1, IEC 60601-1-4, and IEC 60601-1-2 standards. |
2. Sample size used for the test set and the data provenance (e.g., country of origin of the data, retrospective or prospective)
- Test Set Sample Size: Not explicitly stated for any clinical or animal studies. The text mentions "three animal studies" and "a representative sample of the device" for safety testing. This suggests multiple animals were used, but the exact number is not provided.
- Data Provenance:
- Type: Primarily animal studies and bench testing. There is no mention of human clinical trial data for performance evaluation in this summary.
- Country of origin: Not specified.
- Retrospective or Prospective: Animal studies and bench testing are generally prospective in nature.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g., radiologist with 10 years of experience)
Not applicable. The primary performance evaluation described was in animal studies and bench testing; there's no indication of human expert involvement for ground truth establishment in a test set. The intended use states that "The clinical diagnosis of CSF shunt function or malfunction, incorporating the flow information from ShuntCheck, should be made only by a qualified neurosurgeon," implying neurosurgeons are the experts who would ultimately interpret the device's output in a clinical setting, but not for establishing ground truth in a validation study described here.
4. Adjudication method (e.g., 2+1, 3+1, none) for the test set
Not applicable. As no human expert-adjudicated test set is described, there is no mention of an adjudication method.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not performed. The ShuntCheck is a non-invasive thermal convection device, not an AI-assisted diagnostic tool. Therefore, an MRMC study comparing human readers with and without AI assistance is not relevant to this device. The device provides "flow confirmed" or "flow not confirmed" output.
6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done
This is not a software-only "algorithm." It is a physical device (thermosensor array patch connected to a handheld "biodisplay" unit) that detects temperature changes to infer flow. The device itself provides a "flow confirmed" or "flow not confirmed" output, which can be considered its "standalone" output. The studies mentioned (bench testing, animal studies) assessed this device's ability to accurately provide this output. However, it's explicitly stated that "ShuntCheck cannot alone diagnose CSF shunt function or malfunction," and its output must be interpreted by a neurosurgeon.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)
The document implies that the ground truth for the animal studies was based on known flow rates (ml/hr) or the functional state of the shunt (e.g., presence or absence of flow) as established by experimental conditions in the animal models. For bench testing, the ground truth was related to known electrical resistances and expected temperature outputs.
8. The sample size for the training set
The device is not AI/machine learning based and therefore does not have a "training set" in the conventional sense of data used to train an algorithm. The development cycle would involve engineering design, prototyping, and testing, but not and algorithmic training set.
9. How the ground truth for the training set was established
Not applicable, as there is no training set for an AI algorithm.
Ask a specific question about this device
(301 days)
ShuntCheck is indicated for the detection of flow in implanted silastic cerebrospinal Shuid (CSF) shunts. ShuntCheck must be used by a qualified neurosurgeon according to instructions. ShuntCheck cannot, alone diagnose CSF shunt function or malfunction. The clinical diagnosis of CSF shunt function or malfunction, incorporating the flow information from ShuntCheck, should be made only by a qualified neurosurgeon.
Not Found
I am sorry, but the provided text does not contain the detailed information needed to describe the acceptance criteria and the study that proves the device meets them. The document is a 510(k) clearance letter for a device called "ShuntCheck," indicating that the FDA has determined it is substantially equivalent to legally marketed predicate devices.
While it mentions the indications for use, it does not include:
- A table of acceptance criteria and reported device performance.
- Details about sample sizes, data provenance, or the number and qualifications of experts for ground truth.
- Information on adjudication methods.
- Any mention of multi-reader multi-case (MRMC) studies or standalone algorithm performance.
- The type of ground truth used in studies.
- Sample size and ground truth establishment for a training set (which would be relevant for devices involving AI/ML, but less so for a 2004 device like ShuntCheck which likely relies on physical principles).
Therefore, I cannot fulfill your request based on the given text.
Ask a specific question about this device
Page 1 of 1